The Phase 1 successfully met its primary outcome measures, demonstrating that UB-312 was generally well-tolerated and induced anti-aggregated α-synuclein (αSyn) antibody responses in healthy volunteers and PD patients. Specifically, 12 of 13 PD patients who completed dosing developed anti-αSyn antibodies
Parkinson’s Active Immunotherapy Medicine... - Cure Parkinson's
Parkinson’s Active Immunotherapy Medicine Phase 1 Study Positive Results Published
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
Results published in Figure 3, charts E and F, of this study: nature.com/articles/s41591-...
UPDRS part two got better but part 3 got worse, net result they canceled each other out. Small sample but this was a 44 week study, so I personally do not find this result particularly encouraging.
Not what you're looking for?
You may also like...
Phase 3 Positive Topline Results for Tavapadon
Tavapadon met the primary endpoint in the pivotal Phase 3 TEMPO-3 adjunctive trial,...
Oral BIIB122/DNL151 Safely Lowers LRRK2 Activity in Phase 1 Trials
disease, according to results from two Phase 1 clinical studies....
Compounds in Chinese Herbal Medicine May Treat Parkinson’s, Study Suggests
com/2020/04/17/chinese-herbal-medicine-contains-active-compounds-with-potential-treat-parkinsons-stu
Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PD
treatment-naive patients received 1,000 mg NR or placebo for 30 days. NR treatment was well...
5-HTP / serotonin and symptom reduction
PD patients to realize PD directly reduces serotonin that leads to depression symptoms. Patients and
Related Posts
- Can we give CuATSM a try without waiting for the Australian trial completion (5 years from now)
- Taiwan reveals new findings to treat Parkinson's disease
- How much significant is this news?
The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study
The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study
